Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
C$0.87 B
Marketcap
C$24.92
Share price
-0.91%
Change (1 day)
-46.04%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): C$0.70

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is C$0.72. In 2025 the company made an earnings per share (EPS) of C$1.06 an increase over its 2024 EPS that were of C$0.87.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.70-33.85%
2025C$1.0621.69%
2024C$0.8721.02%
2023C$0.72